NCT06194357 Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers
| NCT ID | NCT06194357 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | COVID-19 Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-01-30 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2023-01-30 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
COVID-19-related depression, anxiety, and stigma are expected to have short-term and long-term adverse impacts on mental health, help seeking and preventive behaviours in affected individuals, including care providers and the general population. Health qigong (HQ), a form of traditional Chinese martial arts with emphasis placed on the body movement and status of mind, has been demonstrated to enhance both physical and mental health. Mindfulness-based interventions (MBIs), another mind-body treatment, have become increasingly popular for treating a number of health problems. This study proposes an integrated intervention that combines the effects of HQ and MBIs (iMBHQ) to improve the mental wellbeing of COVID-19 survivors, caregivers including healthcare providers and family members as well as the general public in the community.
Eligibility Criteria
Inclusion Criteria: * COVID-19 survivors: people aged 18 years or above who were infected by COVID-19 (both symptomatic and asymptomatic) and clinically recovered * Caregivers of COVID-19 patients, including family members or medical professionals who have contacts with patients diagnosed COVID-19 aged 18 years or above * General healthy public aged 18 years or above Exclusion Criteria: * people diagnosed severe and/or chronic conditions that prevent the practice of Qigong (e.g., acute exacerbation of dyspnoea, severe cardiopulmonary disease) or mindfulness intervention, * people with severe psychiatric disorder * people who have regular psychiatric follow-ups
Contact & Investigator
Wing Hong, Hector TSANG, Prof
PRINCIPAL INVESTIGATOR
Department of Rehabilitation Science, Faculty of Health and Social Sciences
Frequently Asked Questions
Who can join the NCT06194357 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COVID-19 Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06194357 currently recruiting?
Yes, NCT06194357 is actively recruiting participants. Contact the research team at tk120@ha.org.hk for enrollment information.
Where is the NCT06194357 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06194357 clinical trial?
NCT06194357 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Wing Hong, Hector TSANG, Prof at Department of Rehabilitation Science, Faculty of Health and Social Sciences. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.